- Home
- GPRO vs LYEL Comparison
GPRO vs LYEL Comparison
Compare GPRO & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPRO
- LYEL
- Stock Information
- Founded
- GPRO 2004
- LYEL 2018
- Country
- GPRO United States
- LYEL United States
- Employees
- GPRO N/A
- LYEL N/A
- Industry
- GPRO Industrial Machinery/Components
- LYEL Biotechnology: Pharmaceutical Preparations
- Sector
- GPRO Consumer Discretionary
- LYEL Health Care
- Exchange
- GPRO Nasdaq
- LYEL Nasdaq
- Market Cap
- GPRO 118.4M
- LYEL 207.7M
- IPO Year
- GPRO 2014
- LYEL 2021
- Fundamental
- Price
- GPRO $0.74
- LYEL $9.69
- Analyst Decision
- GPRO Hold
- LYEL Sell
- Analyst Count
- GPRO 1
- LYEL 2
- Target Price
- GPRO $1.50
- LYEL $15.00
- AVG Volume (30 Days)
- GPRO 5.2M
- LYEL 232.0K
- Earning Date
- GPRO 08-05-2025
- LYEL 08-06-2025
- Dividend Yield
- GPRO N/A
- LYEL N/A
- EPS Growth
- GPRO N/A
- LYEL N/A
- EPS
- GPRO N/A
- LYEL N/A
- Revenue
- GPRO $780,312,000.00
- LYEL $65,000.00
- Revenue This Year
- GPRO N/A
- LYEL N/A
- Revenue Next Year
- GPRO $6.79
- LYEL N/A
- P/E Ratio
- GPRO N/A
- LYEL N/A
- Revenue Growth
- GPRO N/A
- LYEL N/A
- 52 Week Low
- GPRO $0.40
- LYEL $7.65
- 52 Week High
- GPRO $1.76
- LYEL $38.40
- Technical
- Relative Strength Index (RSI)
- GPRO 47.74
- LYEL 51.52
- Support Level
- GPRO $0.67
- LYEL $8.46
- Resistance Level
- GPRO $0.95
- LYEL $9.84
- Average True Range (ATR)
- GPRO 0.06
- LYEL 0.86
- MACD
- GPRO -0.02
- LYEL -0.05
- Stochastic Oscillator
- GPRO 26.26
- LYEL 47.00
About GPRO GoPro Inc.
GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts and accessories, lifestyle gear, applications, and subscriptions and services. The company sells products across the world through retailers, distributors, and on GoPro.com. Its hardware products are designed and developed in the United States, France, China, and Romania, and a majority of the manufacturing is outsourced to contract manufacturers located in China, Thailand, and Vietnam. Geographically, the company generates maximum revenue from the Americas, followed by Europe, Middle East and Africa (EMEA), and Asia and Pacific (APAC) region.
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.